Prime Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2021 to Q3 2024.
- Prime Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.83M, a 61.9% increase year-over-year.
- Prime Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $24.6M, a 104% increase year-over-year.
- Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.9M, a 115% increase from 2022.
- Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.46M, a 270% increase from 2021.
- Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.75M, a 347% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)